Anti-obesity and anti-diabetic bioactive peptides: A comprehensive review of their sources, properties, and techno-functional challenges

Tolulope Joshua Ashaolu, Opeyemi Joshua Olatunji, Asli Can Karaca, Chi Ching Lee, Seid Mahdi Jafari*

*Bu çalışma için yazışmadan sorumlu yazar

Araştırma sonucu: ???type-name???İnceleme makalesibilirkişi

Özet

The scourge of obesity arising from obesogens and poor dieting still ravages our planet as half of the global population may be overweight and obese by 2035. This metabolic disorder is intertwined with type 2 diabetes (T2D), both of which warrant alternative therapeutic options other than clinically approved drugs like orlistat with their tendency of abuse and side effects. In this review, we comprehensively describe the global obesity problem and its connection to T2D. Obesity, overconsumption of fats, the mechanism of fat digestion, obesogenic gut microbiota, inhibition of fat digestion, and natural anti-obesity compounds are discussed. Similar discussions are made for diabetes with regard to glucose regulation, the diabetic gut microbiota, and insulinotropic compounds. The sources and production of anti-obesity bioactive peptides (AOBPs) and anti-diabetic bioactive peptides (ADBPs) are also described while explaining their structure–function relationships, gastrointestinal behaviors, and action mechanisms. Finally, the techno-functional applications of AOBPs and ADBPs are highlighted.

Orijinal dilİngilizce
Makale numarası114427
DergiFood Research International
Hacim187
DOI'lar
Yayın durumuYayınlandı - Tem 2024

Bibliyografik not

Publisher Copyright:
© 2024 Elsevier Ltd

Parmak izi

Anti-obesity and anti-diabetic bioactive peptides: A comprehensive review of their sources, properties, and techno-functional challenges' araştırma başlıklarına git. Birlikte benzersiz bir parmak izi oluştururlar.

Alıntı Yap